Roche announced today that Xeloda (capecitabine) in combination with oxaliplatin (a combination known as XELOX) has been approved by the European Medicines Agency (EMEA) for the adjuvant (post-surgery) treatment of patients with early colon cancer.
http://digg.com/u1S2OB
No comments:
Post a Comment